Iressa vs Placebo as Maintenance Therapy in Locally Advanced NSCLC

Summary

The aim of the study if to determine if Iressa can prolong the period of time without any disease worsening (Time to progression) in patients previously treated with combined therapy such as surgery and chemotherapy with or without radiotherapy or chemotherapy and radiotherapy

Timeline

Start

2004-01

Primary completion

—

Completion

2007-08

Drugs

Indications